Literature DB >> 19937193

Outcome based on management for duodenal adenomas: sporadic versus familial disease.

Michael David Johnson1, Richard Mackey, Nancy Brown, James Church, Carol Burke, R Matthew Walsh.   

Abstract

INTRODUCTION: Management and outcomes for duodenal adenomas may vary based on etiology, familial versus sporadic. We reviewed the records of patients managed at our institution for duodenal adenomatous polyps for the 20-year period ending July 2006. DISCUSSION: Methods of polyp resection (endoscopic, local surgical resection, or definitive surgical resection) within both sporadic and familial patient groups were compared. Patients with known cancer were excluded. Two hundred seventy-eight patients with duodenal polyps were followed during this time period: 110 patients (39.6%) with sporadic polyps and 168 (60.4%) with familial adenomatous polyposis (FAP). Sporadic patients presented at a mean age of 66.5 years. Endoscopic resection was attempted in 44 patients (40%) with morbidity in 9% and local recurrence rate of 52% with a mean follow-up of 43 months. Surgical resection was performed in 46 patients (42%): 27 by definitive resection and local resection in 19. At a mean follow-up of 41 months, there were no local recurrences in the patients treated by definitive resection and six recurrences (32%) after local resection. Morbidity was 39%. There was a significant difference in local recurrence when comparing definitive resection to both endoscopic and local resection (p<0.001, p=0.002, respectively), but no significant difference between endoscopic and local excision (p=0.13). Cancer was discovered in the surgical specimens of 11 patients (24%) with benign preoperative biopsies. FAP patients began surveillance at a mean age of 39.5 years, and mean surveillance duration was 100 months. Endoscopic resection/ablation was attempted in 40 patients (24%) with a morbidity of 7.5%. With a mean follow-up of 77.5 months, the local recurrence rate was 72.5%. Surgical resection was performed in with local recurrence rates of 9% and 100%, respectively. Surgical morbidity was 48%. Local recurrence was significantly lower following definitive resection compared to endoscopic or local resection (p<0.001), but there was no difference in local recurrence between the latter two groups (p=0.29). Four patients (8%) undergoing surgery were discovered to have invasive cancer despite benign endoscopic biopsies. In summary, endoscopic and local surgical management for both sporadic and familial duodenal polyps are associated with a high rate of local recurrence. Definitive resection in the form of pancreaticoduodenectomy, pancreas-sparing duodenectomy, or segmental duodenectomy offers the best chance for polyp eradication and prevention of carcinoma, regardless of polyp etiology.

Entities:  

Mesh:

Year:  2010        PMID: 19937193     DOI: 10.1007/s11605-009-1091-4

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  15 in total

1.  Villous tumors of the duodenum: reappraisal of local vs. extended resection.

Authors:  M B Farnell; G H Sakorafas; M G Sarr; C M Rowland; G G Tsiotos; D R Farley; D M Nagorney
Journal:  J Gastrointest Surg       Date:  2000 Jan-Feb       Impact factor: 3.452

Review 2.  Familial adenomatous polyposis.

Authors:  Polymnia Galiatsatos; William D Foulkes
Journal:  Am J Gastroenterol       Date:  2006-02       Impact factor: 10.864

3.  Pancreas-sparing duodenectomy is effective management for familial adenomatous polyposis.

Authors:  Richard Mackey; R Matthew Walsh; Raphael Chung; Nancy Brown; Andrew Smith; James Church; Carol Burke
Journal:  J Gastrointest Surg       Date:  2005-11       Impact factor: 3.452

4.  The natural history of untreated duodenal and ampullary adenomas in patients with familial adenomatous polyposis followed in an endoscopic surveillance program.

Authors:  C A Burke; G J Beck; J M Church; R U van Stolk
Journal:  Gastrointest Endosc       Date:  1999-03       Impact factor: 9.427

5.  Surgical polypectomy of duodenal adenomas in familial adenomatous polyposis: experience of two European centres.

Authors:  C Penna; R K Phillips; E Tiret; A D Spigelman
Journal:  Br J Surg       Date:  1993-08       Impact factor: 6.939

6.  Pylorus-preserving pancreaticoduodenectomy for advanced duodenal disease in familial adenomatous polyposis.

Authors:  M C Gallagher; A Shankar; C J Groves; R C G Russell; R K S Phillips
Journal:  Br J Surg       Date:  2004-09       Impact factor: 6.939

7.  Surveillance of duodenal adenomas in familial adenomatous polyposis reveals high cumulative risk of advanced disease.

Authors:  Jean-Christophe Saurin; Christelle Gutknecht; Bertrand Napoleon; Annick Chavaillon; René Ecochard; Jean-Yves Scoazec; Thierry Ponchon; Jean-Alain Chayvialle
Journal:  J Clin Oncol       Date:  2004-02-01       Impact factor: 44.544

8.  Duodenal adenomatosis in familial adenomatous polyposis.

Authors:  S Bülow; J Björk; I J Christensen; O Fausa; H Järvinen; F Moesgaard; H F A Vasen
Journal:  Gut       Date:  2004-03       Impact factor: 23.059

9.  Utility of a prognostic nomogram designed for gastric cancer in predicting outcome of patients with R0 resected duodenal adenocarcinoma.

Authors:  Jason S Gold; Laura H Tang; Mithat Gönen; Daniel G Coit; Murray F Brennan; Peter J Allen
Journal:  Ann Surg Oncol       Date:  2007-08-07       Impact factor: 5.344

10.  Local resection of ampullary tumors.

Authors:  Adam T Meneghetti; Bassem Safadi; Lygia Stewart; Lawrence W Way
Journal:  J Gastrointest Surg       Date:  2005-12       Impact factor: 3.267

View more
  15 in total

1.  Pancreas-sparing duodenectomy with regional lymph node dissection for early-stage ampullary carcinoma: A case control study using propensity scoring methods.

Authors:  Bin Liu; Jing Li; Yong-Jiu Zhang; Lu-Nan Yan; Sheng-Yi You; Wan-Yee Lau; Hao-Ran Sun; Shi-Yan Yan; Zhi-Qiang Wang
Journal:  World J Gastroenterol       Date:  2015-05-14       Impact factor: 5.742

2.  Endoscopic management of duodenal adenomas in familial adenomatous polyposis--a single-center experience.

Authors:  Sathya Jaganmohan; Patrick M Lynch; Ramu P Raju; William A Ross; Jeffrey E Lee; Gottumukkala S Raju; Manoop S Bhutani; Jason B Fleming; Jeffrey H Lee
Journal:  Dig Dis Sci       Date:  2011-09-30       Impact factor: 3.199

3.  A novel sulindac derivative that potently suppresses colon tumor cell growth by inhibiting cGMP phosphodiesterase and β-catenin transcriptional activity.

Authors:  Jason D Whitt; Nan Li; Heather N Tinsley; Xi Chen; Wei Zhang; Yonghe Li; Bernard D Gary; Adam B Keeton; Yaguang Xi; Ashraf H Abadi; William E Grizzle; Gary A Piazza
Journal:  Cancer Prev Res (Phila)       Date:  2012-05-03

4.  Clinical and endoscopic findings to assist the early detection of duodenal adenoma and adenocarcinoma.

Authors:  Juntaro Matsuzaki; Hidekazu Suzuki; Masayuki Shimoda; Hideki Mori; Seiichiro Fukuhara; Sawako Miyoshi; Tatsuhiro Masaoka; Yasushi Iwao; Yae Kanai; Takanori Kanai
Journal:  United European Gastroenterol J       Date:  2018-12-03       Impact factor: 4.623

5.  Prevalence of gastric and duodenal polyps and risk factors for duodenal neoplasm in korean patients with familial adenomatous polyposis.

Authors:  So Youn Park; Ji Kon Ryu; Ju Hee Park; Hyuk Yoon; Ji Yeon Kim; Yong Bum Yoon; Jae-Gahb Park; Sang Hyub Lee; Sung-Bum Kang; Ji Won Park; Jae Hwan Oh
Journal:  Gut Liver       Date:  2011-03-16       Impact factor: 4.519

Review 6.  Chemoprevention of hereditary colon cancers: time for new strategies.

Authors:  Luigi Ricciardiello; Dennis J Ahnen; Patrick M Lynch
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-04-20       Impact factor: 46.802

7.  CpG island methylator phenotype and its association with malignancy in sporadic duodenal adenomas.

Authors:  Lifeng Sun; Angela A Guzzetta; Tao Fu; Jinming Chen; Jana Jeschke; Ruby Kwak; Rajita Vatapalli; Stephen B Baylin; Christine A Iacobuzio-Donahue; Christopher L Wolfgang; Nita Ahuja
Journal:  Epigenetics       Date:  2014-02-11       Impact factor: 4.528

Review 8.  Nonampullary duodenal adenoma: Current understanding of its diagnosis, pathogenesis, and clinical management.

Authors:  Chul-Hyun Lim; Young-Seok Cho
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

9.  Upper gastrointestinal neoplasia in familial adenomatous polyposis: prevalence, endoscopic features and management.

Authors:  Fábio Guilherme Campos; Carlos Augusto Real Martinez; Marianny Sulbaran; Leonardo Alfonso Bustamante-Lopez; Adriana Vaz Safatle-Ribeiro
Journal:  J Gastrointest Oncol       Date:  2019-08

10.  Advanced duodenal neoplasia and carcinoma in familial adenomatous polyposis: outcomes of surgical management.

Authors:  Fábio Guilherme Campos; Carlos Augusto Real Martinez; Leonardo Alfonso Bustamante Lopez; Danilo Toshio Kanno; Sérgio Carlos Nahas; Ivan Cecconello
Journal:  J Gastrointest Oncol       Date:  2017-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.